Download PDF
Kinder- und Jugendmedizin 2011; 11(06): 315-322
DOI: 10.1055/s-0038-1629162
Dermatologie
Schattauer GmbH

Pruritus

Pruritus
S. A. Grundmann
1   Kompetenzzentrum Chronischer Pruritus, Klinik und Poliklinik für Hautkrankheiten, Universitätsklinikum Münster
,
S. Ständer
1   Kompetenzzentrum Chronischer Pruritus, Klinik und Poliklinik für Hautkrankheiten, Universitätsklinikum Münster
› Author Affiliations
Further Information

Publication History

Eingereicht am:08 September 2011

angenommen am:20 September 2011

Publication Date:
31 January 2018 (online)

    Permissions and Reprints

Zusammenfassung

Einige Erkrankungen des Kindesalters sind mit Pruritus vergesellschaftet. Dabei kann akuter vom chronischen, über 6 Wochen dauernden, Pruritus unterschieden werden. Chronischer Pruritus ist mit einer Prävalenz von 2–3 % bei Kindern seltener als bei Erwachsenen, kann jedoch im Rahmen von Dermatosen schon bei Säuglingen beobachtet werden. Die Pruritusintensität und vermutlich auch die Qualität können jedoch erst von Kindern über 6 Jahren sicher angegeben werden. Akuter und auch chronischer Pruritus tritt bei Kindern am häufigsten im Rahmen von Dermatosen, wie der atopischen Dermatitis, der Psoriasis sowie bei systemischem Erkrankungen, z. B. cholestatischen Lebererkrankungen auf. Obwohl eine dialysepflichtige Niereninsuffizienz bei Erwachsenen ein häufiger Grund für chronischen Pruritus ist (Prävalenz 20 %), leiden nur ca. 9 % der dialysepflichtigen Kinder an diesem Symptom. ZNS-Tumoren sind ein seltener Grund für einen lokalisierten neuropathischen Pruritus. Seltener sind Medikamentennebenwirkungen anzulasten. Für Kinder sind anerkannte systemische antipruritische Therapien aufgrund der eingeschränkten Studienlage nicht verfügbar, wobei Naltrexon, Gabapentin und Cyclosporin A bei chronischem Pruritus im Kindesalter in kleinen Fallserien als wirksam nachgewiesen wurden.

Summary

Several childhood diseases are associated with pruritus. Acute pruritus has to be distinguished from chronic pruritus (>6 weeks). Chronic pruritus is less frequent in children (2–3 % prevalence) than in adults, but can be observed even in infants with dermatological diseases. Pruritus intensity and probably also quality can be differentiated in children by the age of 6 years. In children, acute and chronic pruritus occurs most often in different dermatoses like atopic dermatitis or psoriasis and in cholestatic liver diseases. Though renal insufficiency is a common reason for chronic pruritus in adults (prevalence 20 %), only 9 % of children with dialysis report on chronic pruritus. CNS tumours are a rare reason for localized neuropathic pruritus. Drug side effects are uncommon. Most of systemically antipruritic therapies cannot be applied in children due to a lack of studies, however, in small studies, naltrexone, gabapentine and cyclosporine have proven efficacy in small case series in children with chronic pruritus.

Schlüsselwörter

Atopische Dermatitis - akuter Pruritus - antipruritische Therapie

Keywords

Atopic dermatitis - acute pruritus - antipruritic therapy
 

  • Literatur

  • 1 Gul U, Cakmak SK, Gonul M. et al Pediatric skin disorders encountered in a dermatology outpatient clinic in Turkey. Pediatr Dermatol 2008; 25: 277-278.
    CrossrefPubMedGoogle Scholar
  • 2 Eichenfield LF, Frieden IJ, Esterly NB. Textbook of neonatal dermatology Philadelphia: WB Saunders Company; 2001
  • 3 Wahlgren CF. Children's rating of itch: an experimental study. Pediatr Dermatol 2005; 22: 97-101.
    CrossrefPubMedGoogle Scholar
  • 4 Schneider G. Psychosomatische Einflussfaktoren und psychische Störungen bei chronischem Pruritus. In Ständer (Hrsg) S. Pruritus.. Bremen: Uni Med Science; 2008: 65-70.
    Google Scholar
  • 5 Kupfer J, Keins P, Brosig B. et al Development of questionnaires on coping with disease and itching cognitions for children and adolescents with atopic eczema. Dermatol Psychosom 2003; 4: 79-85.
    CrossrefGoogle Scholar
  • 6 Prehler M, Kupfer J, Brahler E. The Giessen Symptom Questionnaire for children and adolescents. Psychother Psychosom Med Psychol 1992; 42: 71-77.
    PubMedGoogle Scholar
  • 7 Weisshaar E, Diepgen TL, Bruckner T. et al Itch intensity evaluated in the German Atopic Dermatitis Intervention Study (GADIS): correlations with quality of life, coping behaviour and SCORAD severity in 823 children. Acta Derm Venereol 2008; 88: 234-239.
    Google Scholar
  • 8 Ständer S, Streit M, Darsow U. et al AWMF-Sk2 Leitlinie Chronischer Pruritus.. www.awmf.org
    Google Scholar
  • 9 Weisshaar E, Diepgen TL, Luger TA. et al Pruritus in pregnancy and childhood -do we really consider all relevant differential diagnoses?. Eur J Dermatol 2005; 15: 320-331.
    PubMedGoogle Scholar
  • 10 Werfel T, Aberer W, Augustin M. et al Atopic dermatitis: S2 guidelines. J Dtsch Dermatol Ges 2009; 7 (Suppl. 01) (Suppl) S1-46.
    CrossrefPubMedGoogle Scholar
  • 11 Amon U, Hartmann K, Horny HP, Nowak A. Mastocytosis - an update. J Dtsch Dermatol Ges; 8 695-711. quiz 2
    Google Scholar
  • 12 Zuberbier T, Asero R, Bindslev-Jensen C. et al EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64: 1417-1426.
    CrossrefPubMedGoogle Scholar
  • 13 Zuberbier T, Asero R, Bindslev-Jensen C. et al EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64: 1427-1443.
    CrossrefPubMedGoogle Scholar
  • 14 Church MK, Weller K, Stock P, Maurer M. Chronic spontaneous urticaria in children: itching for insight. Pediatr Allergy Immunol 2011; 22: 1-8.
    CrossrefPubMedGoogle Scholar
  • 15 Eberlein B, Eicke C, Reinhardt HW, Ring J. Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study). J Eur Acad Dermatol Venereol 2008; 22: 73-82.
    PubMedGoogle Scholar
  • 16 Stander S. Chronic pruritus: principals of diagnostics and therapy. Hautarzt 2007; 58: 627-636.
    CrossrefPubMedGoogle Scholar
  • 17 Simon D. Systemic therapy of atopic dermatitis in children and adults. Curr Probl Dermatol 2011; 41: 156-64.
    PubMedGoogle Scholar
  • 18 Zellos A, Roy A, Schwarz KB. Use of oral naltrexone for severe pruritus due to cholestatic liver disease in children. J Pediatr Gastroenterol Nutr 2010; 51: 787-789.
    CrossrefPubMedGoogle Scholar
  • 19 Ezzat MH, Hasan ZE, Shaheen KY. Serum measurement of interleukin-31 (IL-31) in paediatric atopic dermatitis: elevated levels correlate with severity scoring. J Eur Acad Dermatol Venereol 2011; 25: 334-339.
    CrossrefPubMedGoogle Scholar
  • 20 Grundmann S, Ständer S. Chronic pruritus: clinics and treatment. Ann Dermatol 2011; 23: 1-11.
    CrossrefPubMedGoogle Scholar
  • 21 Colombo C, Vajro P, Degiorgio D. et al Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations. J Pediatr Gastroenterol Nutr 2011; 52: 73-83.
    CrossrefPubMedGoogle Scholar
  • 22 Kremer AE, Beuers U, Oude-Elferink RP, Pusl T. Pathogenesis and treatment of pruritus in cholestasis. Drugs 2008; 68: 2163-2182.
    CrossrefPubMedGoogle Scholar
  • 23 Cies JJ, Giamalis JN. Treatment of cholestatic pruritus in children. Am J Health Syst Pharm 2007; 64: 1157-1162.
    CrossrefPubMedGoogle Scholar
  • 24 Cynamon HA, Andres JM, Iafrate RP. Rifampin relieves pruritus in children with cholestatic liver disease. Gastroenterology 1990; 98: 1013-1016.
    CrossrefPubMedGoogle Scholar
  • 25 Dinler G, Kocak N, Yuce A. et al Ursodeoxycholic acid therapy in children with cholestatic liver disease. Turk J Pediatr 1999; 41: 91-98.
    PubMedGoogle Scholar
  • 26 El-Karaksy H, Mansour S, El-Sayed R. et al Safety and efficacy of rifampicin in children with cholestatic pruritus. Indian J Pediatr 2007; 74: 279-281.
    CrossrefPubMedGoogle Scholar
  • 27 Narkewicz MR, Smith D, Gregory C. et al Effect of ursodeoxycholic acid therapy on hepatic function in children with intrahepatic cholestatic liver disease. J Pediatr Gastroenterol Nutr 1998; 26: 49-55.
    CrossrefPubMedGoogle Scholar
  • 28 Yerushalmi B, Sokol RJ, Narkewicz MR. et al Use of rifampin for severe pruritus in children with chronic cholestasis. J Pediatr Gastroenterol Nutr 1999; 29: 442-447.
    CrossrefPubMedGoogle Scholar
  • 29 Chang Y, Golkar L. The use of naltrexone in the management of severe generalized pruritus in biliary atresia: report of a case. Pediatr Dermatol 2008; 25: 403-404.
    CrossrefPubMedGoogle Scholar
  • 30 Javouhey E, Ranchin B, Lachaux A. et al Long-lasting extracorporeal albumin dialysis in a child with end-stage renal disease and severe cholestasis. Pediatr Transplant 2009; 13: 235-239.
    CrossrefPubMedGoogle Scholar
  • 31 Pares A, Herrera M, Aviles J. et al Treatment of resistant pruritus from cholestasis with albumin dialysis: combined analysis of patients from three centers. J Hepatol 2010; 53: 307-312.
    CrossrefPubMedGoogle Scholar
  • 32 Mettang T, Pauli-Magnus C, Alscher DM. Uraemic pruritus -new perspectives and insights from recent trials. Nephrol Dial Transplant 2002; 17: 1558-1563.
    CrossrefPubMedGoogle Scholar
  • 33 Senturk N, Ozkaya O, Aytekin S. et al Characteristics of pruritus in children on peritoneal dialysis. Nephron Clin Pract 2008; 109: 168-172.
    CrossrefPubMedGoogle Scholar
  • 34 Pisoni RL, Wikstrom B, Elder SJ. et al Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2006; 21: 3495-3505.
    CrossrefPubMedGoogle Scholar
  • 35 Ständer S, Weisshaar E, Luger TA. Neurophysiological and neurochemical basis of modern pruritus treatment. Exp Dermatol 2008; 17: 161-169.
    CrossrefPubMedGoogle Scholar
  • 36 Naini AE, Harandi AA, Khanbabapour S. et al Gabapentin: a promising drug for the treatment of uremic pruritus. Saudi J Kidney Dis Transpl 2007; 18: 378-381.
    PubMedGoogle Scholar
  • 37 Ahuja RB, Gupta R, Gupta G, Shrivastava P. A comparative analysis of cetirizine, gabapentin and their combination in the relief of post-burn pruritus. Burns 2011; 37: 203-207.
    CrossrefPubMedGoogle Scholar
  • 38 Mendham JE. Gabapentin for the treatment of itching produced by burns and wound healing in children: a pilot study. Burns 2004; 30: 851-853.
    CrossrefPubMedGoogle Scholar
  • 39 Johnson RE, Kanigsberg ND, Jimenez CL. Localized pruritus: a presenting symptom of a spinal cord tumor in a child with features of neurofibromatosis. J Am Acad Dermatol 2000; 43: 958-961.
    CrossrefPubMedGoogle Scholar
  • 40 Magilner D. Localized cervical pruritus as the presenting symptom of a spinal cord tumor. Pediatr Emerg Care 2006; 22: 746-747.
    CrossrefPubMedGoogle Scholar
  • 41 Summers CG, MacDonald JT. Paroxysmal facial itch: a presenting sign of childhood brainstem glioma. J Child Neurol 1988; 3: 189-192.
    CrossrefPubMedGoogle Scholar
  • 42 Hochstrasser H, Boltshauser E, Valavanis A. Brain tumors in children with von Recklinghausen neurofibromatosis. Neurofibromatosis 1988; 1: 233-239.
    PubMedGoogle Scholar
  • 43 Halvorson H, Crooks J, Lahart DA, Farrell KP. An outbreak of itching in an elementary school-a case of mass psychogenic response. J Sch Health 2008; 78: 294-297.
    CrossrefPubMedGoogle Scholar
  • 44 Stein TR, Sonty N, Saroyan J. Scratching“ beneath the surface: An integrative psychosocial approach to pediatric pruritus and pain.. Clin Child Psychol Psychiatry 2011 in press
    PubMedGoogle Scholar
  • 45 Ganemo A, Wahlgren CF, Svensson A. Quality of Life and Clinical Features in Swedish Children with Psoriasis. Pediatr Dermatol 2011; 28: 375-379.
    CrossrefPubMedGoogle Scholar
  • 46 Poindexter G, Morrell DS. Anogenital pruritus: lichen sclerosus in children. Pediatr Ann 2007; 36: 785-791.
    CrossrefPubMedGoogle Scholar
  • 47 van Scheppingen C, Lettinga AT, Duipmans JC. et al Main problems experienced by children with epidermolysis bullosa: a qualitative study with semistructured interviews. Acta Derm Venereol 2008; 88: 143-150.
    CrossrefPubMedGoogle Scholar
  • 48 Jongen J, Eberstein A, Peleikis HG. et al Perianal streptococcal dermatitis: an important differential diagnosis in pediatric patients. Dis Colon Rectum 2008; 51: 584-587.
    CrossrefPubMedGoogle Scholar
  • 49 Schwartz R, Rehder K, Parsons DJ, Morrell DS. Intense pruritus and failure to thrive in Alagille syndrome. J Am Acad Dermatol 2008; 58 (Suppl. 02) (Suppl) S9-11.
    CrossrefPubMedGoogle Scholar
  • 50 Choudhuri AH, Dharmani P, Kumarl N, Prakash A. Comparison of caudal epidural bupivacaine with bupivacaine plus tramadol and bupivacaine plus ketamine for postoperative analgesia in children. Anaesth Intensive Care 2008; 36: 174-179.
    Google Scholar
  • 51 Leonardi S, Marchese G, Rotolo N. et al Cyclosporin is safe and effective in severe atopic dermatitis of childhood. Report of three cases. Minerva Pediatr 2004; 56: 231-237.
    PubMedGoogle Scholar
  • 52 Frigon C, Desparmet J. Ondansetron treatment in a child presenting with chronic intractable pruritus. Pain Res Manag 2006; 11: 245-247.
    PubMedGoogle Scholar